2025. Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life. Research, Society and Development. 14, 5 (May 2025), e4914548812. DOI:https://doi.org/10.33448/rsd-v14i5.48812.